ABSORB Studies Continue to Hint at Promise

ACC Conference Reporter

ESC 2015 | LONDON — A pair of studies reported here confirm that the Absorb everolimus-eluting, bioresorbable vascular scaffold is at least as good as the everolimus-eluting Xience stent, but there is still no evidence of superiority -- a disappointment for many who had hoped bioabsorbable technology would rapidly prove itself superior. Read More >>>

Keywords: ESC Congress


< Back to Listings